FILE:BMY/BMY-8K-20051214164514.txt.gz
EVENTS:	Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
TEXT:
ITEM: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
 
 
 
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
 
On December 14, 2005, Bristol-Myers Squibb Company (the "Company"), through a wholly-owned subsidiary, borrowed an additional $500 million against its existing $2.5 billion term loan facility. The discussion contained under Item 1.01 of the Company's Form 8-K filed August 11, 2005 is incorporated herein by reference.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


